BGMA: NHS must complete drug reimbursement reforms or face higher bill
• By Eliza Loukou
NHS England and NHS Improvement (NHSE&I) will be forced to pay a “higher drugs bill” unless it “urgently” completes its planned drug reimbursement reforms, the head of the British Generic Manufacturers Association’s (BGMA) has told C+D.
exclusive
Mr Samuels said the drugs reimbursement reforms are “only half complete”
A series of drug reimbursement reforms agreed between the Pharmaceutical Services Negotiating Committee (PSNC) and the government will see the gradual introduction of a new discount deduction system later this year.
Free to registered users
Register to gain full access to C+D and C+D Community content
The National Pharmacy Association (NPA) has announced that it is advising its 6,000 member pharmacies to limit services and reduce opening hours in protest against “unsustainable” funding.
Due to shortages in coal tar scalp ointment, the DHSC has asked the manufacturer of an equivalent product - Sebco - to provide increased stock levels to support patients during this time.
Pharmacies in Scotland have been asked to ensure they have the “appropriate stock” of naloxone – a medicine used to reverse the effects of an opiate overdose – following an “increase in sudden collapse” due to overdoses.
Paydens Pharmacy has announced the rollout of a private prescribing service that allows patients to access same-day care “without needing to see their GP” for £15 per consultation.